MARKOVIC, UROS
 Distribuzione geografica
Continente #
NA - Nord America 381
EU - Europa 186
AS - Asia 161
AF - Africa 65
SA - Sud America 18
OC - Oceania 1
Totale 812
Nazione #
US - Stati Uniti d'America 376
SG - Singapore 121
IT - Italia 100
IE - Irlanda 52
CI - Costa d'Avorio 41
CN - Cina 30
SN - Senegal 19
BR - Brasile 17
BE - Belgio 15
CA - Canada 5
DE - Germania 4
FI - Finlandia 4
HK - Hong Kong 4
IN - India 4
NG - Nigeria 4
CZ - Repubblica Ceca 2
FR - Francia 2
RU - Federazione Russa 2
AU - Australia 1
CH - Svizzera 1
CO - Colombia 1
GB - Regno Unito 1
GR - Grecia 1
LK - Sri Lanka 1
MA - Marocco 1
SE - Svezia 1
UA - Ucraina 1
UZ - Uzbekistan 1
Totale 812
Città #
Santa Clara 117
Singapore 91
Chicago 56
Dublin 52
Abidjan 41
Chandler 35
Civitanova Marche 31
Dakar 19
Boardman 18
Ashburn 17
Brussels 15
Rome 13
Cambridge 9
Catania 9
Lawrence 9
Andover 6
Florence 6
Abuja 4
Des Moines 4
Hong Kong 4
Los Angeles 4
Milan 4
Helsinki 3
Jacksonville 3
Naples 3
San Francisco 3
Washington 3
Assago 2
Bremen 2
Council Bluffs 2
Godhra 2
Mascalucia 2
Nanaimo 2
Norwalk 2
Palermo 2
Pedara 2
Redwood City 2
Trecastagni 2
Turin 2
Wilmington 2
Augusto Corrêa 1
Barbacena 1
Beijing 1
Brno 1
Bronte 1
Campinas 1
Casablanca 1
Colombo 1
Cornate D'adda 1
Cosenza 1
Cuneo 1
Eusébio 1
Fairfield 1
Fort St. James 1
Frankfurt Am Main 1
Fronteira 1
Gravataí 1
Handan 1
Hanover 1
Jandira 1
Jaú 1
Lappeenranta 1
Macapá 1
Marino 1
Markham 1
Medellín 1
Melbourne 1
Montes Claros 1
New York 1
Olomouc 1
Pavia 1
Perpignan 1
Porto Seguro 1
Presidente Prudente 1
Ribeirão das Neves 1
Saint Petersburg 1
Seattle 1
Senador Camará 1
Shanghai 1
São Bernardo do Campo 1
São João de Meriti 1
Tashkent 1
Toronto 1
Torre A Mare 1
Volta Redonda 1
Totale 650
Nome #
Plasticity of High-Density Neutrophils in Multiple Myeloma is Associated with Increased Autophagy via STAT3 74
Clinical Benefit of Long-Term Disease Control with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients 68
Serum free light chains and multiple myeloma: Is it time to extend their application? 54
Second-line dasatinib therapy improved compliance and deep molecular responses in imatinib-intolerant chronic myeloid leukemia patients 52
A rare case of multiple myeloma with intracranial extramedullary relapse: One or more myeloma clones? 52
The role of ponatinib in adult BCR-ABL1 positive acute lymphoblastic leukemia after allogeneic transplantation: a real-life retrospective multicenter study 51
VEXAS-like syndrome: a potential new entity? 51
Deferasirox in the management of iron overload in patients with myelofibrosis treated with ruxolitinib: The multicentre retrospective RUX-IOL study 51
Relapse of immune-mediated thrombotic thrombocytopenic purpura following mRNA COVID-19 vaccination: a prospective cohort study 46
Second primary malignancy in myelofibrosis patients treated with ruxolitinib 46
Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network 45
Myelofibrosis and Survival Prognostic Models: A Journey between Past and Future 43
Myeloma Patient With Brugada Syndrome and Successful Lenalidomide Treatment 42
Reduced Absolute Count of Monocytes in Patients Carrying Hematological Neoplasms and SARS-CoV2 Infection 42
Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life Survey 41
Multiple Myeloma in 2023 Ways: From Trials to Real Life 40
Role of Serum Free Light Chain Assay in Relapsed/Refractory Multiple Myeloma. A Real-Life Unicentric Retrospective Study 38
No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the BCR::ABL1 Transcript Level 1
Totale 837
Categoria #
all - tutte 4.286
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.286


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 0 0 0 0 0 0 1 1
2020/202110 0 0 2 1 1 1 3 0 0 0 2 0
2021/202262 5 7 1 1 7 2 9 2 4 3 0 21
2022/2023185 10 11 6 8 16 24 1 34 47 0 22 6
2023/2024177 9 40 6 9 5 39 7 16 0 3 25 18
2024/2025400 12 81 30 54 90 61 5 11 23 32 1 0
Totale 837